Showing results (11-20 of 139) with videos related to
Sort By:
Pageof 14
Kidney International|September 24, 2018
Evocalcet in the management of secondary hyperparathyroidism in dialysis patientsPatrick S ParfreyMethods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Randomized Controlled Trials 7: On Contamination and Estimating the Actual Treatment EffectPatrick S ParfreyCirculation. Arrhythmia and Electrophysiology|March 12, 2016
Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator TherapyKathleen A Hodgkinson, A J Howes, Paul Boland, et al.Current Opinion in Nephrology and Hypertension|October 6, 2005
The clinical epidemiology of cardiovascular disease in chronic kidney diseaseJohn Shik, Patrick S ParfreyMethods in Molecular Biology (Clifton, N.J.)|April 19, 2021
On Framing the Research Question and Choosing the Appropriate Research DesignPatrick S Parfrey, Pietro RavaniMethods in Molecular Biology (Clifton, N.J.)|February 20, 2015
On framing the research question and choosing the appropriate research designPatrick S Parfrey, Pietro RavaniHealthcare Management Forum|July 12, 2011
The breast cancer hormone receptor retesting controversy in Newfoundland and Labrador, Canada: lessons for the health systemDeborah M Gregory, Patrick S ParfreyMethods in Molecular Biology (Clifton, N.J.)|February 20, 2015
Randomized controlled trials 7: Analysis and interpretation of quality-of-life scoresRobert N Foley, Patrick S ParfreyKidney International|August 3, 2012
Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)Tilman B Drüeke, Patrick S ParfreyNature Reviews. Nephrology|February 2, 2011
Sudden cardiac death in chronic kidney disease: epidemiology and preventionM Khaled Shamseddin, Patrick S ParfreyPageof 14